552 related articles for article (PubMed ID: 12319251)
1. The case for a lower dose pill. Assessing the impact of estrogen dose.
Brown S; Cropfield O
ORGYN; 1995; (2):36-9. PubMed ID: 12319251
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
4. [Vascular disease and hormonal treatment--epidemiology].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
6. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
7. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
8. [Stroke and combined oral contraceptives].
Rancurel G; Kieffer E; Buge A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):137-46. PubMed ID: 12280200
[TBL] [Abstract][Full Text] [Related]
9. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
Lidegaard O
Ugeskr Laeger; 1993 Nov; 155(44):3538-45. PubMed ID: 8236574
[TBL] [Abstract][Full Text] [Related]
10. [Oral contraceptives and blood platelets].
Davenas E; Ciavatti M; Poitevin B; Aubin M
Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
[TBL] [Abstract][Full Text] [Related]
11. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
12. [Contraception for women over 40].
Erny R; Mathet M
Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
[TBL] [Abstract][Full Text] [Related]
13. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
14. [Progestins and arterial disease].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):344-52. PubMed ID: 12280205
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Ishak R; Loh Chooi Khim
Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
[TBL] [Abstract][Full Text] [Related]
16. [Contraception for the diabetic woman].
Arlot S; Mesmacque A; Lalau JD; Quichaud J
Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
[TBL] [Abstract][Full Text] [Related]
17. [Veins and contraception].
Reinharez D; Monsonego J
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
[TBL] [Abstract][Full Text] [Related]
18. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
[TBL] [Abstract][Full Text] [Related]
19. [Oestrogen containing oral contraceptives decrease prostacyclin production (author's transl)].
Ylikorkala O; Puolakka J; Vinnikka L
Contracept Fertil Sex (Paris); 1981 Sep; 9(9):547-9. PubMed ID: 12337641
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraception, glucid metabolism and monitoring criteria].
Gaspard U
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
